BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24379071)

  • 21. Role of plasma nitric oxide in complete hydatidiform mole.
    Harma M; Harma M; Kocyigit A; Demir N
    Eur J Gynaecol Oncol; 2004; 25(3):333-5. PubMed ID: 15171312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of pre-evacuation ultrasound examination in histologically confirmed hydatidiform mole in missed abortion.
    Tang Y; Zhu C; Zhu C; Liang F; Lee A; Yao X; Chen Q
    BMC Womens Health; 2020 Sep; 20(1):196. PubMed ID: 32912152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydatidiform mole in Turkey: results from six centers.
    Oge T; Ozalp SS; Güngör T; Yildirim Y; Sanci M; Dogan A; Ertas IE; Yetimalar H; Dilek S; Celik C
    J Reprod Med; 2012; 57(5-6):259-61. PubMed ID: 22696823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K; Satgunasingam N; Nasri NM; Ng KY
    Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete hydatidiform mole in women aged 40 to 49 years.
    Elias KM; Shoni M; Bernstein M; Goldstein DP; Berkowitz RS
    J Reprod Med; 2012; 57(5-6):254-8. PubMed ID: 22696822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of serum inhibin, 17 beta-estradiol and progesterone in cases of hydatidiform mole.
    Hegab HM; Schindler AE
    Gynecol Endocrinol; 2004 Feb; 18(2):107-13. PubMed ID: 15195503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hysteroscopy in the diagnosis and treatment of residua after evacuation of hydatidiform mole].
    Wilczak M; Sajdak S; Woźniak J; Cwojdziński M; Nowak-Markwitz E; Pisarski T
    Ginekol Pol; 1994 Sep; 65(9):522-6. PubMed ID: 7536698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete hydatidiform mole with coexisting normal fetus-report of two cases.
    Margolis K; Maher M; Sidhu M
    Aust N Z J Obstet Gynaecol; 1999 Nov; 39(4):511-3. PubMed ID: 10687779
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful pregnancy following conservative surgical therapy of an invasive molar gestation.
    Rowan SP; Stitely ML; Toffle RC
    W V Med J; 2010; 106(3):24-5. PubMed ID: 21736152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Snowstorms and grape clusters.
    Rose MZ; Jeronis SL; Grotegut CA
    Am J Obstet Gynecol; 2008 May; 198(5):605.e1-2. PubMed ID: 18455547
    [No Abstract]   [Full Text] [Related]  

  • 40. Predictive value of some hematological parameters for non-invasive and invasive mole pregnancies.
    Abide Yayla C; Özkaya E; Yenidede I; Eser A; Ergen EB; Tayyar AT; Şentürk MB; Karateke A
    J Matern Fetal Neonatal Med; 2018 Feb; 31(3):271-277. PubMed ID: 28093002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.